We are a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.
$10.00 - $10.00
May 7, 2019
LEERINK SWANN & COMPANY, NEEDHAM & COMPANY, LLC
To view the prospectus for Trevi Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277